COVID-19 Vaccine Nasal Spray
Rita Rubin
Abstract
Administering the Oxford/AstraZeneca COVID-19 vaccine through the nose reduced viral shedding in animal models, a recent study led by a National Institute of Allergy and Infectious Diseases (NIAID) scientist found.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyViral sheddingNoseNasal sprayNasal administrationInfectious disease (medical specialty)VirusInternal medicineSurgeryDiseaseOutbreakSinusitis and nasal conditionsOtitis Media and Relapsing PolychondritisDrug-Induced Adverse Reactions